These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25152656)

  • 21. Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED Trials.
    Jha MK; South C; Trivedi J; Minhajuddin A; Rush AJ; Trivedi MH
    Int J Neuropsychopharmacol; 2019 May; 22(5):339-348. PubMed ID: 30958879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life: the ultimate outcome measure of interventions in major depressive disorder.
    IsHak WW; Greenberg JM; Balayan K; Kapitanski N; Jeffrey J; Fathy H; Fakhry H; Rapaport MH
    Harv Rev Psychiatry; 2011; 19(5):229-39. PubMed ID: 21916825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.
    Jha MK; Minhajuddin A; Thase ME; Jarrett RB
    J Affect Disord; 2014; 167():37-43. PubMed ID: 25082112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
    Rethorst CD; Sunderajan P; Greer TL; Grannemann BD; Nakonezny PA; Carmody TJ; Trivedi MH
    Psychol Med; 2013 Apr; 43(4):699-709. PubMed ID: 23171815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and functional outcomes of patients who experience partial response to citalopram: secondary analysis of STAR*D.
    Dennehy EB; Marangell LB; Martinez J; Balasubramani GK; Wisniewski SR
    J Psychiatr Pract; 2014 May; 20(3):178-87. PubMed ID: 24847991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.
    Mrazek DA; Biernacka JM; McAlpine DE; Benitez J; Karpyak VM; Williams MD; Hall-Flavin DK; Netzel PJ; Passov V; Rohland BM; Shinozaki G; Hoberg AA; Snyder KA; Drews MS; Skime MK; Sagen JA; Schaid DJ; Weinshilboum R; Katzelnick DJ
    J Clin Psychopharmacol; 2014 Jun; 34(3):313-7. PubMed ID: 24743713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine Learning Prediction of Quality of Life Improvement During Antidepressant Treatment of Patients With Major Depressive Disorder: A STAR*D and CAN-BIND-1 Report.
    Phaterpekar T; Nunez JJ; Morton E; Liu YS; Cao B; Frey BN; Milev RV; Müller DJ; Rotzinger S; Soares CN; Taylor VH; Uher R; Kennedy SH; Lam RW
    J Clin Psychiatry; 2023 Nov; 85(1):. PubMed ID: 37967350
    [No Abstract]   [Full Text] [Related]  

  • 28. The recovery index: A novel approach to measuring recovery and predicting remission in major depressive disorder.
    IsHak WW; Bonifay W; Collison K; Reid M; Youssef H; Parisi T; Cohen RM; Cai L
    J Affect Disord; 2017 Jan; 208():369-374. PubMed ID: 27810720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study.
    Perlis RH; Fraguas R; Fava M; Trivedi MH; Luther JF; Wisniewski SR; Rush AJ
    J Clin Psychiatry; 2005 Feb; 66(2):159-66; quiz 147, 273-4. PubMed ID: 15705000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing brief scales for use in clinical practice: the reliability and validity of single-item self-report measures of depression symptom severity, psychosocial impairment due to depression, and quality of life.
    Zimmerman M; Ruggero CJ; Chelminski I; Young D; Posternak MA; Friedman M; Boerescu D; Attiullah N
    J Clin Psychiatry; 2006 Oct; 67(10):1536-41. PubMed ID: 17107244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mindfulness, Quality of Life, and Severity of Depressive Symptoms Among Patients With Schizophrenia and Patients With Major Depressive Disorder.
    Rayan AHR
    J Psychosoc Nurs Ment Health Serv; 2017 May; 55(5):40-50. PubMed ID: 28460148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report.
    Leuchter AF; Husain MM; Cook IA; Trivedi MH; Wisniewski SR; Gilmer WS; Luther JF; Fava M; Rush AJ
    Psychol Med; 2010 Feb; 40(2):239-51. PubMed ID: 19493369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder.
    Tan XW; Seow E; Abdin E; Verma S; Sim K; Chong SA; Subramaniam M
    BMC Psychiatry; 2019 Sep; 19(1):267. PubMed ID: 31477079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
    Rush AJ; Fava M; Wisniewski SR; Lavori PW; Trivedi MH; Sackeim HA; Thase ME; Nierenberg AA; Quitkin FM; Kashner TM; Kupfer DJ; Rosenbaum JF; Alpert J; Stewart JW; McGrath PJ; Biggs MM; Shores-Wilson K; Lebowitz BD; Ritz L; Niederehe G;
    Control Clin Trials; 2004 Feb; 25(1):119-42. PubMed ID: 15061154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex differences in response to citalopram: a STAR*D report.
    Young EA; Kornstein SG; Marcus SM; Harvey AT; Warden D; Wisniewski SR; Balasubramani GK; Fava M; Trivedi MH; John Rush A
    J Psychiatr Res; 2009 Feb; 43(5):503-11. PubMed ID: 18752809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health-related quality of life and symptom severity in Chinese patients with major depressive disorder.
    Cao Y; Li W; Shen J; Malison RT; Zhang Y; Luo X
    Asia Pac Psychiatry; 2013 Dec; 5(4):276-83. PubMed ID: 23857826
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.